drugset / Trial / NCT01313208
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is designed to evaluate the effectiveness of adding etanercept to disease modifying anti-rheumatic drug (DMARD) therapy in patients with moderately active Rheumatoid Arthritis (RA).
Timeline
- Start
- 2011-03
- Primary completion
- 2013-02
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | 50 mg | Subcutaneous |
| Background | Hydroxychloroquine | Small molecule | — | — |
| Background | Leflunomide | Small molecule | — | — |
| Background | Methotrexate | Small molecule | — | — |
| Background | Minocycline | Small molecule | — | — |
| Background | Sulfasalazine | Small molecule | — | — |